Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00966433 · ClinicalTrials.gov registry record · NA
A Comparison of Different Ventilation Strategies in Children Using the Proseal™ Laryngeal Mask Airway
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT00966433: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT00966433 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 33 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00966433, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
The purpose of this research study is to compare difference between breathing by oneself or with the partial help from an anesthesia machine in children under general anesthesia.
Primary Outcome
Differences in End-tidal Carbon Dioxide Compared Between the Spontaneous Ventilation and Pressure Support Ventilation Groups will be calculated by subtracting the mean of End-tidal Carbon Dioxide from the PSV group to the SV group
Interventions
- DEVICE Pressure control ventilation
- PROCEDURE Spontaneous ventilation
- DEVICE Pressure support Ventilation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2009-08 |
| Est. Completion | 2009-10 |
| Phase | NA |
What the finished NCT00966433 record still lists
NCT00966433 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Pressure control ventilation is the first listed.
NCT00966433 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00966433 about?
NCT00966433 is a clinical study titled "A Comparison of Different Ventilation Strategies in Children Using the Proseal™ Laryngeal Mask Airway". The purpose of this research study is to compare difference between breathing by oneself or with the partial help from an anesthesia machine in children under general anesthesia.
What is the current status of trial NCT00966433?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2009-08. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00966433?
The interventions under investigation include: Pressure control ventilation (DEVICE), Spontaneous ventilation (PROCEDURE), Pressure support Ventilation (DEVICE).
Who is sponsoring clinical trial NCT00966433?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00966433's enrollment target sits among peer trials
33 1574th of 2000 higher than 423 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia